Send mail to Author

Gemcitabine plus sorafenib versus gemcitabine alone in advanced biliary tract cancer : a double-blind placebo-controlled multicentre phase II AIO study with biomarker and serum programme (Article)

Please indicate your contact information and select, which author you want to contact.



 
  _____    _    _    __   __    _____    ______     ______  
 /  ___|| | || | ||  \ \\/ //  |  ___|| |      \\  /_   _// 
| // __   | || | ||   \   //   | ||__   |  --  //   -| ||-  
| \\_\ || | \\_/ ||   / . \\   | ||__   |  --  \\   _| ||_  
 \____//   \____//   /_//\_\\  |_____|| |______//  /_____// 
  `---`     `---`    `-`  --`  `-----`  `------`   `-----`
 


Back to frontdoor view

OPUS4 Logo